Eric Venker - 25 Oct 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: President & COO
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Issuer symbol: ROIV
Transactions as of: 25 Oct 2022
Net transactions value: -$70,057
Form type: 4
Filing time: 27 Oct 2022, 18:00:30 UTC
Previous filing: 27 Sep 2022
Next filing: 22 Nov 2022
SEC: View on sec.gov

Quoteable Key Fact

"Eric Venker filed Form 4 for Roivant Sciences Ltd. (ROIV) on 27 Oct 2022."

Quick Takeaways

This page summarizes Eric Venker's Form 4 filing for Roivant Sciences Ltd. (ROIV).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 27 Oct 2022, 18:00.

What Changed

Previous filing in this sequence was filed on 27 Sep 2022.
Current net transaction value: -$70,057.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ROIV	Common Shares	Sale	$70,057	-15,922	-1.5%	$4.40	1,049,850	25 Oct 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.
F2	The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Content

Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.

The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.